Test Price
2,800 AED✅ Home Collection Available
SRD5A3 Gene Congenital Disorder of Glycosylation, Type Iq Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
This advanced NGS-based genetic test sequences the entire coding region of the SRD5A3 gene to identify pathogenic variants responsible for Congenital Disorder of Glycosylation Type Iq. With 99.9% diagnostic sensitivity, DHA-licensed mobile phlebotomy, and telephonic clinical guidance, this test provides conclusive diagnostic and carrier information for metabolic specialists.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139)
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
- Clinical Guidance: Telephonic Post-Test Clinical Guidance by a Consultant Medical Geneticist (Lina Osama Zaki Quteineh, DHA 9294403)
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731
Test Overview & Methodology
This advanced NGS-based genetic test sequences the entire coding region of the SRD5A3 gene to identify pathogenic variants responsible for Congenital Disorder of Glycosylation Type Iq (CDG-Iq). The test is performed on whole blood (EDTA), extracted DNA, or a single drop of blood on an FTA card, providing conclusive diagnostic and carrier information for metabolic specialists.
Before sample collection, a mandatory Genetic Counselling session is required to draw a comprehensive pedigree chart documenting all family members affected by CDG-Iq. Please share clinical history and any prior metabolic/genetic reports. Fasting is not necessary for DNA extraction. Ensure cold-chain transport for liquid samples.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | NGS with 99.9% analytical sensitivity for SRD5A3 variants | Single‑gene Sanger sequencing (misses deep intronic variants) |
| Method | Next Generation Sequencing + MLPA backup | Conventional PCR + Sanger |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
“Genetic testing for SRD5A3 provides critical diagnostic confirmation, but results must be interpreted in conjunction with clinical symptoms and family history. I recommend ongoing collaboration with a metabolic specialist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication without consulting your physician. Altering dosage may lead to serious metabolic complications.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: Patients unable to provide informed consent (legal guardian must sign); individuals with active untreated coagulopathy that precludes blood draw; samples not collected in DHA-approved tubes.
- Red Flags – Seek Immediate Emergency Care if: sudden vomiting, unexplained lethargy, seizures, feeding difficulties, or signs of acute metabolic decompensation in the tested individual.
Patient FAQ & Clinical Guidance
1. What is the SRD5A3 gene test and why is it ordered?
This NGS test analyzes the entire SRD5A3 gene to confirm a diagnosis of Congenital Disorder of Glycosylation Type Iq, which typically presents with developmental delay, hypotonia, and abnormal bleeding.
2. How reliable is the home collection service for genetic testing in the UAE?
Our DHA‑licensed mobile phlebotomists use ISO‑certified cold‑chain kits to maintain sample integrity from your doorstep to the lab, ensuring 99.9% sample viability for NGS.
3. Will insurance cover the cost of this genetic test?
Many UAE insurers cover genetic testing for congenital disorders when medically necessary; our team verifies your coverage directly via WhatsApp and assists with pre‑approval forms.
UAE Regulatory & Data Privacy Adherence
All genetic testing and data handling at DNA Labs UAE comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient information is encrypted, stored securely, and never shared without explicit consent. Our DHA-licensed facility adheres to the highest standards of confidentiality and clinical safety.
Clinical & Logistical Metadata
| Test Name | SRD5A3 Gene Congenital Disorder of Glycosylation, Type Iq Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3-4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or One Drop of Blood on FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) + MLPA |
| ICD-10-CM Code | E77.8 |
| LOINC Code | 61738-5 |
| DHA Facility License & Laboratory Address | DHA Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians